Wealthspring Capital’s Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant IBER.U Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-18,040
| Closed | -$180K | – | 202 |
|
|
2022
Q4 | $180K | Sell |
18,040
-177,162
| -91% | -$1.77M | 0.27% | 129 |
|
|
2022
Q3 | $1.93M | Sell |
195,202
-5,210
| -3% | -$51.6K | 0.38% | 67 |
|
|
2022
Q2 | $1.96M | Sell |
200,412
-10,540
| -5% | -$103K | 0.37% | 60 |
|
|
2022
Q1 | $2.07M | Sell |
210,952
-20,230
| -9% | -$198K | 0.41% | 54 |
|
|
2021
Q4 | $2.32M | Sell |
231,182
-19,320
| -8% | -$194K | 0.5% | 43 |
|
|
2021
Q3 | $2.5M | Sell |
250,502
-26,690
| -10% | -$267K | 0.6% | 37 |
|
|
2021
Q2 | $2.79M | Sell |
277,192
-16,248
| -6% | -$163K | 0.7% | 29 |
|
|
2021
Q1 | $2.89M | Buy |
+293,440
| New | +$2.89M | 0.78% | 31 |
|